Herbalife Ltd. (NYSE:HLF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Herbalife is a global network marketing company offering a range of science-based weight management products, nutritional supplements and personal care products intended to support weight loss and a healthy lifestyle. “

Several other research analysts have also commented on the stock. TheStreet lowered shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Tuesday, August 9th. SunTrust Banks Inc. reissued a “neutral” rating and set a $66.00 target price on shares of Herbalife in a research report on Friday, August 5th. Finally, Pivotal Research reissued a “buy” rating and set a $90.00 target price on shares of Herbalife in a research report on Sunday, July 17th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $68.72.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/herbalife-ltd-hlf-stock-rating-lowered-by-zacks-investment-research.html

Herbalife (NYSE:HLF) traded up 0.79% during trading on Wednesday, reaching $60.93. 716,608 shares of the company were exchanged. The stock has a market capitalization of $5.66 billion, a P/E ratio of 20.88 and a beta of 1.72. Herbalife has a 1-year low of $42.26 and a 1-year high of $72.22. The company’s 50-day moving average price is $63.17 and its 200-day moving average price is $61.23.

Herbalife (NYSE:HLF) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.29 EPS for the quarter, topping the consensus estimate of $1.21 by $0.08. The firm earned $1.20 billion during the quarter, compared to analyst estimates of $1.19 billion. Herbalife had a net margin of 5.55% and a negative return on equity of 2,099.28%. Herbalife’s revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.24 EPS. On average, equities analysts forecast that Herbalife will post $1.31 EPS for the current year.

In other news, insider Shin-Shing Bosco Chiu sold 2,000 shares of the company’s stock in a transaction on Friday, July 15th. The shares were sold at an average price of $68.00, for a total value of $136,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Carl C. Icahn acquired 2,304,683 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was acquired at an average cost of $59.31 per share, for a total transaction of $136,690,748.73. The disclosure for this purchase can be found here. 4.91% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP increased its stake in Herbalife by 31.7% in the second quarter. GSA Capital Partners LLP now owns 56,821 shares of the company’s stock valued at $3,326,000 after buying an additional 13,679 shares during the period. M&T Bank Corp purchased a new stake in shares of Herbalife during the first quarter worth about $340,000. BlackRock Group LTD increased its stake in shares of Herbalife by 3.2% in the first quarter. BlackRock Group LTD now owns 294,521 shares of the company’s stock worth $18,131,000 after buying an additional 9,010 shares during the period. BlackRock Inc. increased its stake in shares of Herbalife by 90.0% in the first quarter. BlackRock Inc. now owns 10,017 shares of the company’s stock worth $617,000 after buying an additional 4,745 shares during the period. Finally, Algert Global LLC increased its stake in shares of Herbalife by 44.3% in the first quarter. Algert Global LLC now owns 14,261 shares of the company’s stock worth $878,000 after buying an additional 4,381 shares during the period.

Herbalife Company Profile

Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company’s segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China.

5 Day Chart for NYSE:HLF

Receive News & Ratings for Herbalife Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.